Analysts Set Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Target Price at $32.86
Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) has been given a consensus rating of “Buy” by the eight research firms that are covering the firm, MarketBeat.com reports. Eight equities research analysts have rated the stock with a buy rating. The average 1 year price target among brokerages that have issued ratings on the stock […]
Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) has been given a consensus rating of “Buy” by the eight research firms that are covering the firm, MarketBeat.com reports. Eight equities research analysts have rated the stock with a buy rating. The average 1 year price target among brokerages that have issued ratings on the stock […]
